Topological folding and proteolysis profile of P-glycoprotein in membranes of multidrug-resistant cells: Implications for the drug-transport mechanism

被引:46
作者
Zhang, M
Wang, GC
Shapiro, A
Zhang, JT
机构
[1] UNIV TEXAS,MED BRANCH,DEPT PHYSIOL & BIOPHYS,GALVESTON,TX 77555
[2] BRITISH COLUMBIA CANC RES CTR,VANCOUVER,BC V5Z 1L3,CANADA
关键词
D O I
10.1021/bi960400s
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
P-glycoprotein (Pgp)(1) is 3 polytopic membrane protein and functions as an energy-dependent drug efflux pump. It is responsible for multidrug resistance (MDR) in cancer cell lines. Recently, tile topological structure of Pgp has been investigated. However, the results Lire in dispute. A major question concerning the Pgp topology is the membrane orientation of tile loop linking TM4 and TM5 (loop 1) and the loop linking TM8 and TM9 (loop 8). in this study, we generated polyclonal antibodies specific to these two loops. Tn combination with a panel of other well-characterized site-specific polyclonal and monoclonal antibodies of Pep, we tested the membrane orientation of these two loops of Pgp in multidrug-resistant cells using immunocytochemistry and proteolysis/membrane protection assay. Our results showed that (1) both loops 4 and 8 are located extracellularly whereas other domains, such as the ATP-binding sites. are in the cytoplasm and (2) proteolysis of Pgp is not a random event and the trypsin-sensitive sites are cleaved in orders, Since the Pgp was not genetically manipulated in this study. in contrast to previous studies, we believe that naturally expressed Pgp molecules have an unconventional topology. We speculate that this alternate topology of Pgp may represent a different functional state of the protein. Further detailed analysis of Pgp topology will help to understand thr fundamental mechanism of drug transport by Pgp.
引用
收藏
页码:9728 / 9736
页数:9
相关论文
共 37 条
[1]  
ALVES C, 1993, J BIOL CHEM, V268, P20148
[2]  
[Anonymous], 1988, Antibodies: A Laboratory Manual
[3]  
BEJA O, 1995, J BIOL CHEM, V270, P12351
[4]   PROTEINS OF HUMAN ERYTHROCYTE-MEMBRANE AS MODIFIED BY PRONASE [J].
BENDER, WW ;
GARAN, H ;
BERG, HC .
JOURNAL OF MOLECULAR BIOLOGY, 1971, 58 (03) :783-+
[5]  
BIBI E, 1994, J BIOL CHEM, V269, P19910
[6]   CLASSICAL AND NOVEL FORMS OF MULTIDRUG-RESISTANCE AND THE PHYSIOLOGICAL FUNCTIONS OF P-GLYCOPROTEINS IN MAMMALS [J].
BORST, P ;
SCHINKEL, AH ;
SMIT, JJM ;
WAGENAAR, E ;
VANDEEMTER, L ;
SMITH, AJ ;
EIJDEMS, EWHM ;
BAAS, F ;
ZAMAN, GJR .
PHARMACOLOGY & THERAPEUTICS, 1993, 60 (02) :289-299
[7]  
BRADLEY G, 1989, CANCER RES, V49, P2790
[8]   A METHOD FOR THE DETERMINATION OF INORGANIC-PHOSPHATE IN THE PRESENCE OF LABILE ORGANIC PHOSPHATE AND HIGH-CONCENTRATIONS OF PROTEIN - APPLICATION TO LENS ATPASES [J].
CHIFFLET, S ;
TORRIGLIA, A ;
CHIESA, R ;
TOLOSA, S .
ANALYTICAL BIOCHEMISTRY, 1988, 168 (01) :1-4
[9]  
Childs S, 1994, Important Adv Oncol, P21
[10]  
CIANFRIGLIA M, 1994, INT J CANCER, V56, P153